Pre-order Enquiry
Request Free Sample
Global Vaccine Conjugate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
SKU ID : GIR-21184496 | Publishing Date : 02-Jul-2022 | No. of pages : 98
Detailed TOC of Global Vaccine Conjugate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
1 Market Overview1.1 Vaccine Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine Conjugate Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine Conjugate Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adult
1.4 Global Vaccine Conjugate Market Size & Forecast
1.4.1 Global Vaccine Conjugate Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vaccine Conjugate Sales in Volume (2017-2028)
1.4.3 Global Vaccine Conjugate Price (2017-2028)
1.5 Global Vaccine Conjugate Production Capacity Analysis
1.5.1 Global Vaccine Conjugate Total Production Capacity (2017-2028)
1.5.2 Global Vaccine Conjugate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine Conjugate Market Drivers
1.6.2 Vaccine Conjugate Market Restraints
1.6.3 Vaccine Conjugate Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Vaccine Conjugate Product and Services
2.1.4 Pfizer Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Vaccine Conjugate Product and Services
2.2.4 GSK Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Vaccine Conjugate Product and Services
2.3.4 Sanofi Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Vaccine Conjugate Product and Services
2.4.4 Merck Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Walvax Biotechnology
2.5.1 Walvax Biotechnology Details
2.5.2 Walvax Biotechnology Major Business
2.5.3 Walvax Biotechnology Vaccine Conjugate Product and Services
2.5.4 Walvax Biotechnology Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Royal (Wuxi) Bio-Pharmaceutical
2.6.1 Royal (Wuxi) Bio-Pharmaceutical Details
2.6.2 Royal (Wuxi) Bio-Pharmaceutical Major Business
2.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product and Services
2.6.4 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bharat Biotech
2.7.1 Bharat Biotech Details
2.7.2 Bharat Biotech Major Business
2.7.3 Bharat Biotech Vaccine Conjugate Product and Services
2.7.4 Bharat Biotech Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhifei Biologic
2.8.1 Zhifei Biologic Details
2.8.2 Zhifei Biologic Major Business
2.8.3 Zhifei Biologic Vaccine Conjugate Product and Services
2.8.4 Zhifei Biologic Vaccine Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Vaccine Conjugate Breakdown Data by Manufacturer
3.1 Global Vaccine Conjugate Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vaccine Conjugate Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vaccine Conjugate
3.4 Market Concentration Rate
3.4.1 Top 3 Vaccine Conjugate Manufacturer Market Share in 2021
3.4.2 Top 6 Vaccine Conjugate Manufacturer Market Share in 2021
3.5 Global Vaccine Conjugate Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vaccine Conjugate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vaccine Conjugate Market Size by Region
4.1.1 Global Vaccine Conjugate Sales in Volume by Region (2017-2028)
4.1.2 Global Vaccine Conjugate Revenue by Region (2017-2028)
4.2 North America Vaccine Conjugate Revenue (2017-2028)
4.3 Europe Vaccine Conjugate Revenue (2017-2028)
4.4 Asia-Pacific Vaccine Conjugate Revenue (2017-2028)
4.5 South America Vaccine Conjugate Revenue (2017-2028)
4.6 Middle East and Africa Vaccine Conjugate Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Vaccine Conjugate Sales in Volume by Type (2017-2028)
5.2 Global Vaccine Conjugate Revenue by Type (2017-2028)
5.3 Global Vaccine Conjugate Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Vaccine Conjugate Sales in Volume by Application (2017-2028)
6.2 Global Vaccine Conjugate Revenue by Application (2017-2028)
6.3 Global Vaccine Conjugate Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Vaccine Conjugate Sales by Type (2017-2028)
7.2 North America Vaccine Conjugate Sales by Application (2017-2028)
7.3 North America Vaccine Conjugate Market Size by Country
7.3.1 North America Vaccine Conjugate Sales in Volume by Country (2017-2028)
7.3.2 North America Vaccine Conjugate Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Vaccine Conjugate Sales by Type (2017-2028)
8.2 Europe Vaccine Conjugate Sales by Application (2017-2028)
8.3 Europe Vaccine Conjugate Market Size by Country
8.3.1 Europe Vaccine Conjugate Sales in Volume by Country (2017-2028)
8.3.2 Europe Vaccine Conjugate Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Vaccine Conjugate Sales by Type (2017-2028)
9.2 Asia-Pacific Vaccine Conjugate Sales by Application (2017-2028)
9.3 Asia-Pacific Vaccine Conjugate Market Size by Region
9.3.1 Asia-Pacific Vaccine Conjugate Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vaccine Conjugate Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Vaccine Conjugate Sales by Type (2017-2028)
10.2 South America Vaccine Conjugate Sales by Application (2017-2028)
10.3 South America Vaccine Conjugate Market Size by Country
10.3.1 South America Vaccine Conjugate Sales in Volume by Country (2017-2028)
10.3.2 South America Vaccine Conjugate Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vaccine Conjugate Sales by Type (2017-2028)
11.2 Middle East & Africa Vaccine Conjugate Sales by Application (2017-2028)
11.3 Middle East & Africa Vaccine Conjugate Market Size by Country
11.3.1 Middle East & Africa Vaccine Conjugate Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vaccine Conjugate Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Vaccine Conjugate and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vaccine Conjugate
12.3 Vaccine Conjugate Production Process
12.4 Vaccine Conjugate Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vaccine Conjugate Typical Distributors
13.3 Vaccine Conjugate Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Figures, Tables and Charts Available in Global Vaccine Conjugate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
List of TablesTable 1. Global Vaccine Conjugate Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Vaccine Conjugate Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Vaccine Conjugate Product and Services
Table 6. Pfizer Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Vaccine Conjugate Product and Services
Table 10. GSK Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Vaccine Conjugate Product and Services
Table 14. Sanofi Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Vaccine Conjugate Product and Services
Table 18. Merck Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 20. Walvax Biotechnology Major Business
Table 21. Walvax Biotechnology Vaccine Conjugate Product and Services
Table 22. Walvax Biotechnology Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Royal (Wuxi) Bio-Pharmaceutical Major Business
Table 25. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product and Services
Table 26. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 28. Bharat Biotech Major Business
Table 29. Bharat Biotech Vaccine Conjugate Product and Services
Table 30. Bharat Biotech Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zhifei Biologic Basic Information, Manufacturing Base and Competitors
Table 32. Zhifei Biologic Major Business
Table 33. Zhifei Biologic Vaccine Conjugate Product and Services
Table 34. Zhifei Biologic Vaccine Conjugate Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Vaccine Conjugate Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 36. Global Vaccine Conjugate Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Vaccine Conjugate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Vaccine Conjugate Production Capacity by Company, (K Doses): 2020 VS 2021
Table 39. Head Office and Vaccine Conjugate Production Site of Key Manufacturer
Table 40. Vaccine Conjugate New Entrant and Capacity Expansion Plans
Table 41. Vaccine Conjugate Mergers & Acquisitions in the Past Five Years
Table 42. Global Vaccine Conjugate Sales by Region (2017-2022) & (K Doses)
Table 43. Global Vaccine Conjugate Sales by Region (2023-2028) & (K Doses)
Table 44. Global Vaccine Conjugate Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Vaccine Conjugate Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)
Table 47. Global Vaccine Conjugate Sales by Type (2023-2028) & (K Doses)
Table 48. Global Vaccine Conjugate Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Vaccine Conjugate Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Vaccine Conjugate Price by Type (2017-2022) & (USD/Dose)
Table 51. Global Vaccine Conjugate Price by Type (2023-2028) & (USD/Dose)
Table 52. Global Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)
Table 53. Global Vaccine Conjugate Sales by Application (2023-2028) & (K Doses)
Table 54. Global Vaccine Conjugate Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Vaccine Conjugate Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Vaccine Conjugate Price by Application (2017-2022) & (USD/Dose)
Table 57. Global Vaccine Conjugate Price by Application (2023-2028) & (USD/Dose)
Table 58. North America Vaccine Conjugate Sales by Country (2017-2022) & (K Doses)
Table 59. North America Vaccine Conjugate Sales by Country (2023-2028) & (K Doses)
Table 60. North America Vaccine Conjugate Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Vaccine Conjugate Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)
Table 63. North America Vaccine Conjugate Sales by Type (2023-2028) & (K Doses)
Table 64. North America Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)
Table 65. North America Vaccine Conjugate Sales by Application (2023-2028) & (K Doses)
Table 66. Europe Vaccine Conjugate Sales by Country (2017-2022) & (K Doses)
Table 67. Europe Vaccine Conjugate Sales by Country (2023-2028) & (K Doses)
Table 68. Europe Vaccine Conjugate Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Vaccine Conjugate Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)
Table 71. Europe Vaccine Conjugate Sales by Type (2023-2028) & (K Doses)
Table 72. Europe Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)
Table 73. Europe Vaccine Conjugate Sales by Application (2023-2028) & (K Doses)
Table 74. Asia-Pacific Vaccine Conjugate Sales by Region (2017-2022) & (K Doses)
Table 75. Asia-Pacific Vaccine Conjugate Sales by Region (2023-2028) & (K Doses)
Table 76. Asia-Pacific Vaccine Conjugate Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Vaccine Conjugate Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)
Table 79. Asia-Pacific Vaccine Conjugate Sales by Type (2023-2028) & (K Doses)
Table 80. Asia-Pacific Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)
Table 81. Asia-Pacific Vaccine Conjugate Sales by Application (2023-2028) & (K Doses)
Table 82. South America Vaccine Conjugate Sales by Country (2017-2022) & (K Doses)
Table 83. South America Vaccine Conjugate Sales by Country (2023-2028) & (K Doses)
Table 84. South America Vaccine Conjugate Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Vaccine Conjugate Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)
Table 87. South America Vaccine Conjugate Sales by Type (2023-2028) & (K Doses)
Table 88. South America Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)
Table 89. South America Vaccine Conjugate Sales by Application (2023-2028) & (K Doses)
Table 90. Middle East & Africa Vaccine Conjugate Sales by Region (2017-2022) & (K Doses)
Table 91. Middle East & Africa Vaccine Conjugate Sales by Region (2023-2028) & (K Doses)
Table 92. Middle East & Africa Vaccine Conjugate Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Vaccine Conjugate Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)
Table 95. Middle East & Africa Vaccine Conjugate Sales by Type (2023-2028) & (K Doses)
Table 96. Middle East & Africa Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)
Table 97. Middle East & Africa Vaccine Conjugate Sales by Application (2023-2028) & (K Doses)
Table 98. Vaccine Conjugate Raw Material
Table 99. Key Manufacturers of Vaccine Conjugate Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Vaccine Conjugate Typical Distributors
Table 103. Vaccine Conjugate Typical Customers
List of Figures
Figure 1. Vaccine Conjugate Picture
Figure 2. Global Vaccine Conjugate Revenue Market Share by Type in 2021
Figure 3. Hib Vaccine
Figure 4. Meningococcal Vaccine
Figure 5. Pneumococcal Vaccine
Figure 6. Others
Figure 7. Global Vaccine Conjugate Revenue Market Share by Application in 2021
Figure 8. Children
Figure 9. Adult
Figure 10. Global Vaccine Conjugate Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global Vaccine Conjugate Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Vaccine Conjugate Sales (2017-2028) & (K Doses)
Figure 13. Global Vaccine Conjugate Price (2017-2028) & (USD/Dose)
Figure 14. Global Vaccine Conjugate Production Capacity (2017-2028) & (K Doses)
Figure 15. Global Vaccine Conjugate Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Vaccine Conjugate Market Drivers
Figure 17. Vaccine Conjugate Market Restraints
Figure 18. Vaccine Conjugate Market Trends
Figure 19. Global Vaccine Conjugate Sales Market Share by Manufacturer in 2021
Figure 20. Global Vaccine Conjugate Revenue Market Share by Manufacturer in 2021
Figure 21. Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Vaccine Conjugate Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Vaccine Conjugate Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Vaccine Conjugate Sales Market Share by Region (2017-2028)
Figure 25. Global Vaccine Conjugate Revenue Market Share by Region (2017-2028)
Figure 26. North America Vaccine Conjugate Revenue (2017-2028) & (USD Million)
Figure 27. Europe Vaccine Conjugate Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Vaccine Conjugate Revenue (2017-2028) & (USD Million)
Figure 29. South America Vaccine Conjugate Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Vaccine Conjugate Revenue (2017-2028) & (USD Million)
Figure 31. Global Vaccine Conjugate Sales Market Share by Type (2017-2028)
Figure 32. Global Vaccine Conjugate Revenue Market Share by Type (2017-2028)
Figure 33. Global Vaccine Conjugate Price by Type (2017-2028) & (USD/Dose)
Figure 34. Global Vaccine Conjugate Sales Market Share by Application (2017-2028)
Figure 35. Global Vaccine Conjugate Revenue Market Share by Application (2017-2028)
Figure 36. Global Vaccine Conjugate Price by Application (2017-2028) & (USD/Dose)
Figure 37. North America Vaccine Conjugate Sales Market Share by Type (2017-2028)
Figure 38. North America Vaccine Conjugate Sales Market Share by Application (2017-2028)
Figure 39. North America Vaccine Conjugate Sales Market Share by Country (2017-2028)
Figure 40. North America Vaccine Conjugate Revenue Market Share by Country (2017-2028)
Figure 41. United States Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Vaccine Conjugate Sales Market Share by Type (2017-2028)
Figure 45. Europe Vaccine Conjugate Sales Market Share by Application (2017-2028)
Figure 46. Europe Vaccine Conjugate Sales Market Share by Country (2017-2028)
Figure 47. Europe Vaccine Conjugate Revenue Market Share by Country (2017-2028)
Figure 48. Germany Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Vaccine Conjugate Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Vaccine Conjugate Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Vaccine Conjugate Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Vaccine Conjugate Revenue Market Share by Region (2017-2028)
Figure 57. China Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Vaccine Conjugate Sales Market Share by Type (2017-2028)
Figure 64. South America Vaccine Conjugate Sales Market Share by Application (2017-2028)
Figure 65. South America Vaccine Conjugate Sales Market Share by Country (2017-2028)
Figure 66. South America Vaccine Conjugate Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Vaccine Conjugate Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Vaccine Conjugate Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Vaccine Conjugate Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Vaccine Conjugate Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Vaccine Conjugate Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Vaccine Conjugate in 2021
Figure 78. Manufacturing Process Analysis of Vaccine Conjugate
Figure 79. Vaccine Conjugate Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Keyplayers in Global Vaccine Conjugate Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
PfizerGSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Request Sample
Request Discount
